Medtronic has announced its acquisition of Digital Surgery, which is a privately-held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training. A press release says that the acquisition will strengthen the Medtronic robotic-assisted surgery platform and has applicability for the Medtronic broader portfolio. The terms of the agreement have been disclosed.
Headquartered in London, UK, Digital Surgery’s mission is to digitise surgical protocols using cutting-edge computing and to support the delivery of consistent, data-driven and evidence-based surgical care. Following the acquisition, Digital Surgery will remain headquartered in London where there are plans for continued investment and workforce expansion. The company’s executive team, including the two surgeon co-founders—Andre Chow and Jean Nehme—will remain in place and continue to provide leadership. Digital Surgery and Medtronic’s co-developed digital solutions are expected to be offered on future Medtronic soft tissue robotic assisted surgery systems.
Nehme states: “Joining Medtronic creates an incredible opportunity to realise the promise of reducing unwarranted variability in surgery. We have always believed in computational power and data as two central drivers of consistency and quality in surgery. Computational power has impacted our lives in so many ways, and within surgery it is almost absent. By joining forces with Medtronic, we will finally apply computing and AI to surgery on a meaningful scale with a goal of helping more patients in more places benefit from consistently high-quality surgical care.”
Megan Rosengarten, vice president and general manager of the Surgical Robotics business, which is part of the Minimally Invasive Therapies Group at Medtronic, notes: “Capabilities and solutions in the data and analytics space play a critical role in our continued focus on advancing minimally invasive surgery—from education and training, to clinical decision support, to reducing cost and unwarranted variability. We are thrilled to bring the Digital Surgery team and their expertise into Medtronic, not only due to the strategic fit from a technology perspective, but due to the shared belief that patients around the world deserve access to quality surgical care. By pairing digital solutions with robotic platforms and instrumentation, we can have a big impact on expanding patient access.”
The transaction is expected to be immaterial to Medtronic’s fiscal 2020 adjusted earnings per share and is expected to meet Medtronic’s long-term financial metrics for acquisitions. Digital Surgery will join the Surgical Robotics business as part of the Minimally Invasive Therapies Group.